Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002052113-25-001470·Artiva Biotherapeutics, Inc.
Schedule 13G ownership disclosure
Artiva Biotherapeutics, Inc.
Common Stock · CUSIP: 04317A107
Event date: 2025-03-31
- Filing-level shares
- 1,245,511
- Percent of class
- 5.1%
- BlackRock, Inc.
Shares: 1,245,511 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-001470
- Form type
- SCHEDULE 13G
- Filer
- Artiva Biotherapeutics, Inc.
- CIK
- CIK 1817241
- Filed
- Apr 23, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership